These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 12608531)

  • 1. Novel ethanol-in-fluorocarbon microemulsions for topical genetic immunization.
    Cui Z; Fountain W; Clark M; Jay M; Mumper RJ
    Pharm Res; 2003 Jan; 20(1):16-23. PubMed ID: 12608531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intradermal immunization with novel plasmid DNA-coated nanoparticles via a needle-free injection device.
    Cui Z; Baizer L; Mumper RJ
    J Biotechnol; 2003 Apr; 102(2):105-15. PubMed ID: 12697387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of co-administration of adjuvants with a nanoparticle-based genetic vaccine delivery system on the resulting immune responses.
    Cui Z; Mumper RJ
    Eur J Pharm Biopharm; 2003 Jan; 55(1):11-8. PubMed ID: 12551699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical immunization using nanoengineered genetic vaccines.
    Cui Z; Mumper RJ
    J Control Release; 2002 May; 81(1-2):173-84. PubMed ID: 11992690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intranasal administration of plasmid DNA-coated nanoparticles results in enhanced immune responses.
    Cui Z; Mumper RJ
    J Pharm Pharmacol; 2002 Sep; 54(9):1195-203. PubMed ID: 12356273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic immunization using nanoparticles engineered from microemulsion precursors.
    Cui Z; Mumper RJ
    Pharm Res; 2002 Jul; 19(7):939-46. PubMed ID: 12180545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical immunization onto mouse skin using a microemulsion incorporated with an anthrax protective antigen protein-encoding plasmid.
    Cui Z; Sloat BR
    Int J Pharm; 2006 Jul; 317(2):187-91. PubMed ID: 16730934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasmid DNA-entrapped nanoparticles engineered from microemulsion precursors: in vitro and in vivo evaluation.
    Cui Z; Mumper RJ
    Bioconjug Chem; 2002; 13(6):1319-27. PubMed ID: 12440869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chitosan-based nanoparticles for topical genetic immunization.
    Cui Z; Mumper RJ
    J Control Release; 2001 Aug; 75(3):409-19. PubMed ID: 11489327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preferential induction of a Th1 immune response and inhibition of specific IgE antibody formation by plasmid DNA immunization.
    Raz E; Tighe H; Sato Y; Corr M; Dudler JA; Roman M; Swain SL; Spiegelberg HL; Carson DA
    Proc Natl Acad Sci U S A; 1996 May; 93(10):5141-5. PubMed ID: 8643542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of both cellular and humoral responses to genetic immunization by co-administration of an antigen-expressing plasmid and a plasmid encoding the pro-apoptotic protein Bax.
    Kinsey BM; Marcelli M; Song L; Bhogal BS; Ittmann M; Orson FM
    J Gene Med; 2004 Apr; 6(4):445-54. PubMed ID: 15079819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The extent of the uptake of plasmid into the skin determines the immune responses induced by a DNA vaccine applied topically onto the skin.
    Yu Z; Chung WG; Sloat BR; Löhr CV; Weiss R; Rodriguez BL; Li X; Cui Z
    J Pharm Pharmacol; 2011 Feb; 63(2):199-205. PubMed ID: 21235583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel transcutaneous plasmid-dimethylsulfoxide delivery technique for avian nucleic acid immunization.
    Heckert RA; Elankumaran S; Oshop GL; Vakharia VN
    Vet Immunol Immunopathol; 2002 Oct; 89(1-2):67-81. PubMed ID: 12208052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunization via hair follicles by topical application of naked DNA to normal skin.
    Fan H; Lin Q; Morrissey GR; Khavari PA
    Nat Biotechnol; 1999 Sep; 17(9):870-2. PubMed ID: 10471927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaxfectin enhances the humoral immune response to plasmid DNA-encoded antigens.
    Hartikka J; Bozoukova V; Ferrari M; Sukhu L; Enas J; Sawdey M; Wloch MK; Tonsky K; Norman J; Manthorpe M; Wheeler CJ
    Vaccine; 2001 Feb; 19(15-16):1911-23. PubMed ID: 11228361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic immunization by jet injection of targeted pDNA-coated nanoparticles.
    Mumper RJ; Cui Z
    Methods; 2003 Nov; 31(3):255-62. PubMed ID: 14511958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved genetic immunization via micromechanical disruption of skin-barrier function and targeted epidermal delivery.
    Mikszta JA; Alarcon JB; Brittingham JM; Sutter DE; Pettis RJ; Harvey NG
    Nat Med; 2002 Apr; 8(4):415-9. PubMed ID: 11927950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic effect of formulated plasmid and needle-free injection for genetic vaccines.
    Anwer K; Earle KA; Shi M; Wang J; Mumper RJ; Proctor B; Jansa K; Ledebur HC; Davis S; Eaglstein W; Rolland AP
    Pharm Res; 1999 Jun; 16(6):889-95. PubMed ID: 10397610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-ionic surfactant based vesicles (niosomes) for non-invasive topical genetic immunization against hepatitis B.
    Vyas SP; Singh RP; Jain S; Mishra V; Mahor S; Singh P; Gupta PN; Rawat A; Dubey P
    Int J Pharm; 2005 May; 296(1-2):80-6. PubMed ID: 15885458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cationic transfersomes based topical genetic vaccine against hepatitis B.
    Mahor S; Rawat A; Dubey PK; Gupta PN; Khatri K; Goyal AK; Vyas SP
    Int J Pharm; 2007 Aug; 340(1-2):13-9. PubMed ID: 17446015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.